Targacept, Inc. Announces Participation in Upcoming Conferences
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today announced that Dr. Stephen A. Hill, President and Chief Executive Officer, is scheduled to present at the following conferences:
•12th Annual Needham Healthcare Conference at the Westin Grand Central Hotel in New York, New York on Tuesday, April 30, 2013 at 12:10 p.m. Eastern Time.
Help employers find you! Check out all the jobs and post your resume.
Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today announced that Dr. Stephen A. Hill, President and Chief Executive Officer, is scheduled to present at the following conferences:
•12th Annual Needham Healthcare Conference at the Westin Grand Central Hotel in New York, New York on Tuesday, April 30, 2013 at 12:10 p.m. Eastern Time.
Help employers find you! Check out all the jobs and post your resume.